Sterility testing results in days, not weeks.
Sapho Bio’s Nucleotide-based platform detects living bacteria and fungi in approximately 2 days, replacing the 14-day standard.
WHO WE ARE
Release Fast. Release with Confidence.
Benefits
The standard hasn't changed. Until now.
Every sterile pharmaceutical product must pass a sterility test before it can be released. For decades, the industry has relied on the same method.
Traditional Method
14 days
Incubate samples for 14 days
Manual visual inspection for turbidity
Drug batches held in quarantine
Capital locked, shelf life consumed
Method introduced decades ago, not designed for modern therapies
Sapho Bio
2 days
Nucleotide-based detection and identification of living organisms
Objective molecular results, not visual inspection
Faster release decisions, less quarantine time
Capital freed, shelf life preserved
Traditional Method
Sapho Bio
WHY NOW
Precision medicines are redefining what "fast enough" means.
Cell therapies, patient-specific products, and biologics with short shelf life cannot afford a 14-day wait. Every hour in quarantine is an hour of usable product life lost — and for some therapies, that window is already narrow.
01
Short Product Shelf Life
Precision therapies often have a shelf life measured in days. Every delay reduces time available for treatment.
02
Idle Inventory
While testing is ongoing, products remain in quarantine. This slows operations and delays time to market.
03
Growing Demand
The precision medicine market is expanding quickly, but testing infrastructure has not kept pace.
04
Legacy Bottleneck
Traditional sterility testing was designed for stable drugs, not time-sensitive therapies.
How it works
Four steps. Faster results.
Our lab service model means you can start testing immediately,
no lengthy onboarding.
Traditional sterility tests rely on visible growth. It works, but it’s slow.
TECHNOLOGY
We detect what's alive at the molecular level.
How it works
Built by scientists. Run for perfection.
Cameron Bravo, PhD
Operations Research Scientist
Experimental high-energy particle physicist with 15 years of experience. Helped build equipment used at CERN. Expertise in large datasets, scientific operations, and instrumentation.
Santhosh Karanth, PhD
Research Scientist
Over a decade in assay development and screening. Specializes in metabolism and genetics. Experience spanning genome editing, biologics, small molecules, and diagnostics.
Ali Palla, PhD
Research Scientist
PhD in Biochemistry and Molecular Biology from UCSF. A decade of protein biochemistry and RNA biology experience studying chromatin modification. Enjoys reading, gaming, and exploring cities.
Abraham Chaibi
CEO
Founded a high-frequency trading firm specializing in black box price prediction models. Enjoys reading and learning about science applications improving American lives.
John McSpedon
CTO
First employee at Merantix, a Berlin-based AI accelerator. Optimized protein materials at Cambrium GmbH. Mined metagenomes for gene editing tools at Arc Institute. Enjoys cycling and rock climbing.
Pavel Ryzhov, PhD
Head of Growth
Biomedicine leader focused on translating complex scientific ideas into clear, compelling growth strategy.
Eunice Pacheco
Head of People
As the Head of People at Sapho Bio, I am passionate about creating workplaces where people feel valued, engaged, and empowered to do their best work. 12 years of experience at ADP.
News
